Search

Your search keyword '"Buhl Roland"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Buhl Roland" Remove constraint Author: "Buhl Roland" Database OAIster Remove constraint Database: OAIster
96 results on '"Buhl Roland"'

Search Results

1. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

2. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

3. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

4. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

5. Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)

6. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

7. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

8. Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study

9. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

10. Development and validation of an electronic daily control score for asthma (e-DASTHMA):a real-world direct patient data study

11. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

12. Development and validation of an electronic daily control score for asthma (e-DASTHMA):a real-world direct patient data study

13. European Respiratory Society guidelines for the diagnosis of asthma in adults

14. European Respiratory Society guidelines for the diagnosis of asthma in adults

15. Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States

16. Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis

17. Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months

18. ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

19. ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

20. ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

21. ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

22. ARIA digital anamorphosis : Digital transformation of health and care in airway diseases from research to practice

23. Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months

24. Cabbage and fermented vegetables:From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

25. Eosinophilic and Noneosinophilic Asthma:An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort

26. Eosinophilic and Noneosinophilic Asthma:An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort

27. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

28. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

29. ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020)

30. Impact of donor lung quality on post-transplant recipient outcome in the Lung Allocation Score era in Eurotransplant - a historical prospective study.

31. Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

32. Impact of donor lung quality on post-transplant recipient outcome in the Lung Allocation Score era in Eurotransplant - a historical prospective study.

33. Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

34. ARIA digital anamorphosis:Digital transformation of health and care in airway diseases from research to practice

35. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

36. ARIA digital anamorphosis:Digital transformation of health and care in airway diseases from research to practice

37. Exceptional LAS Requests in Eurotransplant: Analysis of an 8-year Effort to Improve Lung Allocation for Precarious Patients

38. Impact of donor lung quality on post-transplant recipient outcome in the Lung Allocation Score era in Eurotransplant – a historical prospective study

39. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

40. A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol

41. Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD

42. Impact of donor lung quality on post-transplant recipient outcome in the Lung Allocation Score era in Eurotransplant – a historical prospective study

43. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H

44. Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases

45. Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases

46. Next-generation ARIA care pathways for rhinitis and asthma:a model for multimorbid chronic diseases

47. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

48. Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases

49. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

50. Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases

Catalog

Books, media, physical & digital resources